Afuco™ Anti-Human GD2 ADCC Therapeutic Antibody (hu14.18K322A), ADCC Enhanced
Anti-GD2 ADCC Enhanced Antibody (hu14.18K322A) is an ADCC enhanced antibody produced by our Afuco™ platform. Hu14.18K322A is a monoclonal antibody that is made to bind to cancer cells that have a molecule called GD2 on their surface, designed to decrease toxicity in children with refractory or recurrent neuroblastoma.
| Supplier | Creative Biolabs |
|---|---|
| Product # | AFC-291CL |
| Pricing | Inquiry |
| Host | Humanized |
| Target | GD2 |
| Species Reactivity | Human |
| Type | ADCC enhanced antibody |
| Storage | ≥1 year at -20°C. If the reconstituted antibody cannot be used within two weeks, it should be aliquoted into smaller vials and stored at -20°C |